Search

Sherry Ci Phones & Addresses

  • 1987 San Salvatore Pl, San Marino, CA 91108
  • Pasadena, CA
  • Newport Coast, CA
  • Alhambra, CA
  • Rochester, NY
  • Riverside, CA

Publications

Us Patents

Propofol Formulation Containing Reduced Oil And Surfactants

View page
US Patent:
20040225022, Nov 11, 2004
Filed:
May 9, 2003
Appl. No.:
10/434776
Inventors:
Neil Desai - Pacific Palisades CA, US
Andrew Yang - Rosemead CA, US
Tapas De - Los Angeles CA, US
Sherry Ci - San Marino CA, US
Patrick Soon-Shiong - Los Angeles CA, US
International Classification:
A61K031/05
US Classification:
514/731000
Abstract:
Sterile, stable pharmaceutical formulations of emulsions of neat propofol or propofol dissolved in a solvent and containing no preservative are provided that comprise optimal amounts of surfactants such as lecithin and solvent such as soybean oil, with a suitable pH range to prevent significant growth of microorganisms for at least 24 hours after adventitious, extrinsic contamination. The lower amount of oil or absence (oil) in the formulation also allows chronic sedation over extended periods of time with a reduced chance of lipid overload in the blood.

Compositions And Methods Of Delivery Of Pharmacological Agents

View page
US Patent:
20050004002, Jan 6, 2005
Filed:
Dec 9, 2003
Appl. No.:
10/731224
Inventors:
Neil Desai - Santa Monica CA, US
Andrew Yang - Rosemead CA, US
Tapas De - Los Angeles CA, US
Sherry Ci - San Marino CA, US
Patrick Soon-Shiong - Los Angeles CA, US
Vuong Trieu - Calabasas CA, US
Oiang Yao - Culver City CA, US
Bridget Grim - Torrance CA, US
Assignee:
American BioScience, Inc. - Santa Monica CA
International Classification:
A61K038/13
A61K038/17
A61K031/704
A61K031/337
A61K031/56
A61K031/4745
US Classification:
514002000, 514012000, 514011000, 514291000, 514170000, 514171000, 514449000, 514034000, 514553000, 514567000, 514731000
Abstract:
The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human serum albumin and/or deferoxamine. The human serum albumin is present in an amount effective to reduce one or more side effects associated with administration of the pharmaceutical composition. The invention also provides methods for reducing one or more side effects of administration of the pharmaceutical composition, methods for inhibiting microbial growth and oxidation in the pharmaceutical composition, and methods for enhancing transport and binding of a pharmaceutical agent to a cell.

Propofol Formulations With Non-Reactive Container Closures

View page
US Patent:
20050009731, Jan 13, 2005
Filed:
Jul 10, 2003
Appl. No.:
10/616709
Inventors:
Neil Desai - Pacific Palisades CA, US
Andrew Yang - Rosemead CA, US
Sherry Ci - San Marino CA, US
Assignee:
American BioScience, Inc. - Santa Monica CA
International Classification:
A61K038/00
A61K031/05
US Classification:
514002000, 514731000
Abstract:
A sterile pharmaceutical composition for parenteral administration of propofol, said composition comprising propofol, optionally albumin, and less than about 10% by weight solvent for propofol, wherein said composition is stored in a container having a closure wherein said closure is inert to propofol.

Propofol Formulation Containing Reduced Oil And Surfactants

View page
US Patent:
20070161601, Jul 12, 2007
Filed:
May 7, 2004
Appl. No.:
10/556811
Inventors:
Neil Desai - Santa Monica CA, US
Andrew Yang - Rosemead CA, US
Tapas De - Los Angeles CA, US
Sherry Ci - San Marino CA, US
Patrick Soon-Shiong - Los Angeles CA, US
Assignee:
American BioScience, Inc - Santa Monica CA
International Classification:
A61K 31/685
A61K 31/05
US Classification:
514078000, 514731000
Abstract:
Sterile, stable pharmaceutical formulations of emulsions of neat propofol or propofol dissolved in a solvent and containing no preservative are provided that comprise optimal amounts of surfactants such as lecithin and solvent such as soybean oil, with a suitable pH range to prevent significant growth of microorganisms for at least 24 hours after adventitious, extrinsic contamination. The lower amount of oil or absence (oil) in the formulation also allows chronic sedation over extended periods of time with a reduced chance of lipid overload in the blood.

Propofol Formulation Containing Reduced Oil And Surfactants

View page
US Patent:
20080132582, Jun 5, 2008
Filed:
Jun 4, 2007
Appl. No.:
11/757779
Inventors:
Neil P. Desai - Pacific Palisades CA, US
Andrew Yang - Rosemead CA, US
Tapas De - Los Angeles CA, US
Sherry Xiaopei Ci - San Marino CA, US
Patrick Soon-Shiong - Los Angeles CA, US
Assignee:
Abraxis BioScience, Inc. - Los Angeles CA
International Classification:
A61K 31/05
US Classification:
514731
Abstract:
Sterile, stable pharmaceutical formulations of emulsions of neat propofol or propofol dissolved in a solvent and containing no preservative are provided that comprise optimal amounts of surfactants such as lecithin and solvent such as soybean oil, with a suitable pH range to prevent significant growth of microorganisms for at least 24 hours after adventitious, extrinsic contamination. The lower amount of oil or absence (oil) in the formulation also allows chronic sedation over extended periods of time with a reduced chance of lipid overload in the blood.

Nanoparticle Formulations And Uses Thereof

View page
US Patent:
20130195983, Aug 1, 2013
Filed:
Apr 9, 2010
Appl. No.:
13/263723
Inventors:
Neil P. Desai - Los Angeles CA, US
Chunlin Tao - Los Angeles CA, US
Tapas De - Los Angeles CA, US
Sherry Xiaopei Ci - San Marino CA, US
Vuong Trieu - Calabasas CA, US
International Classification:
A61K 9/14
US Classification:
424491, 514773, 514449, 514776, 424400
Abstract:
The present invention provides compositions comprising nanoparticles comprising: 1) a drug, such as a hydrophobic drug derivative; and 2) a carrier protein. Also provided are methods of treating diseases (such as cancer) using the compositions, as well as kits and unit dosages.

Propofol Formulations With Non-Reactive Container Closures

View page
US Patent:
20130327668, Dec 12, 2013
Filed:
Jun 4, 2013
Appl. No.:
13/909961
Inventors:
Andrew YANG Andrew YANG - Rosemead CA, US
Sherry Xiaopei CI - San Marino CA, US
International Classification:
A61J 1/00
US Classification:
206438
Abstract:
A container storing an anesthetic is disclosed. The container is sealed by a closure and stores a liquid anesthetic solution. The anesthetic is from 0.1% to 10% by weight of the liquid anesthetic solution. The container is made of a material that is inert to the anesthetic and the closure is made of siliconized rubber or a metal. A concentration of the anesthetic in a liquid anesthetic solution stored in the container following a predetermined time period is at least 93% of a concentration of the anesthetic in a liquid anesthetic solution before the liquid anesthetic solution is stored in the container.

Nanoparticle Formulations And Uses Thereof

View page
US Patent:
20140080901, Mar 20, 2014
Filed:
Feb 28, 2013
Appl. No.:
13/781479
Inventors:
Chunlin TAO - Los Angeles CA, US
Tapas DE - Los Angeles CA, US
Sherry X. CI - San Marino CA, US
Vuong TRIEU - Calabasas CA, US
Assignee:
ABRAXIS BIOSCIENCE, LLC - Los Angeles CA
International Classification:
A61K 31/337
US Classification:
514449
Abstract:
The present invention provides compositions comprising nanoparticles comprising: 1) a drug, such as a hydrophobic drug derivative; and 2) a carrier protein. Also provided are methods of treating diseases (such as cancer) using the compositions, as well as kits and unit dosages.
Sherry Xiaopei Ci from San Marino, CA, age ~61 Get Report